home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Pharmaceutical Root Cause Analysis of Failures & Deviations - Developing an Effective CAPA Strategy

 
  March 28, 2016  
     
 
Center for Professional Innovation & Education, Inc., Los Angeles, CA
June 22 – 24, 2016


Inadequate failure investigations continue to be a major GMP deficiency cited during routine and for-cause regulatory inspections. This course highlights FDA and EU regulations and how to successfully approach a failure investigation and engage in subsequent root cause analysis.

The primary objective of this course is to recognize the value of conducting proper root cause analysis and documenting failure investigations. Emphasis is placed on the application and practical, hands-on aspects of how to facilitate root cause analysis. Additionally, the course will provide attendees with the principles and techniques involved in identifying failures and deviations, categorizing problems, assigning responsibility and tracking team activities.

Additional benefits of this class include:

  • Learn not just from the Director, but tap into the knowledge of your peers: Participants will have the opportunity to anonymously submit their challenges, problems, and issues for classroom discussion. Ample time is provided to address specific problems and questions of individual participants
  • Explore the use of brainstorming, process mapping and regulatory resources
  • Participants will also have the opportunity for one-on-one consultation with the Course Director during course breaks and in the evenings
 
 
Organized by: Center for Professional Innovation & Education
Invited Speakers:

Mr. Kerry Potter is the founder of Summit Consulting, Inc. He has more than 30 years of experience in project management, regulatory compliance systems, quality assurance, quality systems audits, regulatory training, employee development, GMP and documentation.

During the past 10 years, Kerry has provided consulting, training and mentoring services to several pharmaceutical firms in the United States and Europe through regulatory remediation activities (e.g. Consent Decree, Warning Letters), training and training systems development, documentation control, and project management.

Mr. Potter gained his pharmaceutical-manufacturing experience during his 28-year career with Merck. His experience spanned quality operations, audits/inspections, laboratory, human resources, and learning & development. His responsibilities included quality inspector, analytical chemist, quality motivation administrator, laboratory quality-management assessment manager, GMP lead auditor, FDA quality-management system manager, 5S coordinator, GMP trainer, OSHA regulations trainer, process safety management training, and internal and external public relations management.

Mr. Potter received his B.S. in Chemistry from James Madison University. He has received qualifications and certifications in quality auditing, facilitation and training – including instructional design and competency-based curricula. His past and current affiliations include ASQ, ASTD, PDA, GMP-TEA, ASPI and AQP.

 
Deadline for Abstracts: n/a
 
Registration: CLICK HERE TO REGISTER
E-mail: info@cfpie.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.